Elanco Animal Health Incorporated (NYSE:ELAN) reported first-quarter adjusted EPS of $0.34, down 26% year over year, beating the consensus of $0.26 and management guidance of $0.25-$0.28. The animal health company’s sales of $1.21 billion were down 4% year over year, beating the consensus of $1.174 billion and guidance of $1.16 billion—$1.185 billion. The ERP Blackout negatively impacted growth by an estimated 7% to 9%. Pet Health revenue was $639 million, down 5% year over year, with a 3% increase in price compared to the first quarter of 2023. Farm Animal revenue was $556 million, down 3%.  Guidance: Elanco Animal Health forecasts 2024 adjusted EPS of $0.88-$0.96 versus prior guidance of ...